Haima Therapeutics LLC
Cleveland, OH
- UEI
- JKZPL4NA9V21
- CAGE
- 7P1L6
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- FY2025 rankings
- Self-certified in SAM.gov
- Entity structure
- Partnership or Limited Liability Partnership
- SAM.gov registration date
- Physical address
- 11000 Cedar Ave # 280, Cleveland, OH 44106, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $1,000,000 |
| FY2025 | $1,000,000 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Defense Advanced Research Projects Agency | $1,000,000 |
Contract awards
Contract subawards
| Prime contractor | Prime award | Amount | Awarded |
|---|---|---|---|
| University Of Maryland, Baltimore | N660012394005 | $31,683 | |
| University Of Maryland, Baltimore | N660012394005 | -$31,683 | |
| University Of Maryland, Baltimore | N660012394005 | $470,778 |
Grant awards
Latest 5 listed here. See the rest on GovTribe.
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| Applied Research Institute Inc. | ED24HDQ0G0469 | $238,000 |
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Fibroplate Inc. | Las Vegas, NV | 325414 Biological Product (except Diagnostic) Manufacturing |
| Coalesenz Inc. | Cambridge, MA | 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| Selsym Biotech Inc. | Cary, NC | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Cellphire, Inc. | Rockville, MD | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Stasys Medical Corp | Kirkland, WA | — |
About the company
Haima Therapeutics LLC is a Cleveland, Ohio-based woman-owned small business and limited liability company registered in SAM.gov since 2016. The organization specializes in developing advanced nanotechnology solutions focused on hemostatic treatments and platelet-inspired therapeutic interventions. Its core expertise appears to center on innovative medical research and development of synthetic platelet technologies that can address critical medical challenges, particularly in trauma and bleeding management scenarios.
Through its federal contract history, Haima Therapeutics LLC has executed a small purchase order valued at $17,500 with the Veterans Integrated Service Network 10, specifically for research involving drug-loaded liposomes. The contract was not set aside for any specific business category and was completed on September 15, 2022. While the contract award history is limited, it suggests the company's capability to perform specialized research-oriented procurement work for federal medical service networks.
Haima Therapeutics LLC has been more prominently engaged through federal grant awards, particularly with the National Heart, Lung, and Blood Institute. Its primary grant work involves developing a novel platelet-inspired nanotechnology called Synthoplate (SP), designed to restore hemostasis in patients using antiplatelet agents. The $944,676 project grant focuses on creating a donor-independent therapeutic to reduce bleeding complications in traumatic brain injury patients. Additionally, the company has participated in a sub-grant with Case Western Reserve University, developing field-deployable dried platelet surrogate nanotechnology for hemorrhage control, specifically targeting military combat-associated traumatic hemorrhage scenarios. These grants demonstrate the company's advanced research capabilities in developing innovative medical technologies with significant potential impact on trauma and emergency medical treatment.
SBA capabilities narrative
Research, development, and commercialization of therapeutic to mitigate bleeding inn non-compressible hemorrhage and other bleeding complications.
Quick answers
Is Haima Therapeutics LLC registered in SAM.gov?
Yes. Haima Therapeutics LLC's SAM.gov registration is active through October 7, 2027.
How much has Haima Therapeutics LLC received in federal contracts?
Federal contracts obligated $1,000,000 to Haima Therapeutics LLC in fiscal year 2025 and $2,000,000 in fiscal years 2023 through 2027.
How does Haima Therapeutics LLC rank among federal contractors?
Haima Therapeutics LLC ranked #38 in PSC AC15 in FY2025.
What is Haima Therapeutics LLC's most recent federal award?
Haima Therapeutics LLC's most recent federal contract award is IND-enabling preclinical evaluation of a field-deployable synthetic (HR0011259E017), from Defense Advanced Research Projects Agency, on September 19, 2025.
On GovTribe
See Haima Therapeutics LLC's full federal record
- Federal contract awards
- IDV awards
- Federal grant awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors